Table 4. Multivariate analysis of prognostic factors for TTP.

Variable		n (%)	TTP
			HR(95% CI), p value
Treatment	TACE	67 (25.2%)	1 [Reference]
	TACE plus JD	75 (28.2%)	0.5 (0.4, 0.8) 0.005
	TACE plus Sorafenib	124 (46.6%)	1.0 (0.7, 1.4) 0.978
Extrahepatic metastasis	Absent	215 (81.1%)	1 [Reference]
	Present	50 (18.9%)	1.8 (1.2, 2.6) 0.004
Aspartate transaminase (IU/L)	< 64	181 (68.3%)	1 [Reference]
	≥ 64	84 (31.7%)	1.6 (1.2, 2.2) 0.004
Serum albumin (g/L)	≥ 35	215 (80.8%)	1 [Reference]
	< 35	51 (19.2%)	1.6 (1.1, 2.3) 0.027

Abbrevations: TTP, time to progression; TACE, transarterial chemoembolization; JD, Jie-du.